NEW YORK, March 20 (Reuters) - Just weeks after prosecutors accused Forest Laboratories Inc of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians ...
On April 20, the FDA approved a revision to the safety labeling for citalopram hydrobromide and escitalopram oxalate (Celexa and Lexapro, respectively, made by Forest Laboratories) in tablet and oral ...
The U.S. Department of Justice has filed a complaint against Forest Laboratories, the maker of antidepressants Celexa and Lexapro, accusing it of being underhanded in how it disclosed its research.
ST. LOUIS (CN) – Forest Pharmaceuticals and Forest Laboratories illegally marketed two antidepressant drugs, Celexa and Lexapro, a class action claims in Federal Court. Named plaintiffs ...
The Supreme Court meant what it said in China Agritech, Inc. v. Resh – that is the primary lesson from the First Circuit’s January 30 th decision in In re Celexa and Lexapro Marketing and Sales ...
Forest Pharmaceuticals Inc. and Forest Laboratories Inc. are facing multiple proposed class actions in which the plaintiffs allege antidepressants Celexa and Lexapro were unlawfully marketed to treat ...
Fed. Judge Kicks 15 Celexa and Lexapro Cases to State Court A federal judge in Camden, N.J., has remanded to state court 15 suits over birth defects in children born to mothers who took Forest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results